Advertisement

Topics

NeuroMetrix Company Profile

00:22 EDT 22nd October 2017 | BioPortfolio

NeuroMetrix, Inc. was founded in June 1996 as a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. The Company’s mission is to: Create value for our customers by developing innovative neurological diagnostic and therapeutic solutions that maximize quality of care and economic outcomes Produce a superior return on investment for our shareholders Provide our employees with an opportunity for growth so that they may realize their professional potential The Company is accomplishing these goals by utilizing its proprietary technology platform and its core competency in biomedical engineering, neurophysiology and information technology to develop and commercialize a line of novel neurological diagnostic tests and therapeutic interventions. The key elements of the Company's proprietary technology are: Advanced biosensors that communicate bioelectrical signals between physiological tissue, such as peripheral nerves, and electronic instruments. Sophisticated bioelectronic instruments interface with the biosensors and enable diagnostic and therapeutic procedures. Biomedical signal processing, automation and analysis algorithms. Informatics and decision support software that maximizes clinical utility. Markets At the present time, the Company is focused on the tremendous unmet clinical need in point-of-service neurodiagnostic testing created by tens of millions of annual patient visits related to nerve pathology, as well as in very high rates of nerve related repetitive stress disorders in many industries. The Company’s flagship product, the NC-stat® is a nerve conduction-testing platform that has been on the market since 2000. The NC-stat is used by orthopedic surgeons, neurosurgeons, neurologists, physiatrists, rheumatologists, internal medicine physicians, occupational health physicians, pain medicine physicians, general practitioners, and others, to assist in the diagnosis or exclusion of peripheral nerve disorders.

Location

62 Fourth Ave
Waltham
MA
02451
United States of America

Contact

Phone: 781-890-9989
Email: info@neurometrix.com


News Articles [30 Associated News Articles listed on BioPortfolio]

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock

Monday, July 10th 2017 at 10:24pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it has entered into a definitive securities purchase agreement ...

NeuroMetrix Announces Date For 2017 Third Quarter Financial Results Conference Call

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter financial results before the opening of the market on Thursda...

NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017

NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwri...

NeuroMetrix Announces Issuance of New U.S. ...

Read more...

NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter financial results before the opening of the market on Thursday October 19, 2017. Th...

NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 second quarter financial results before the opening of the market on Thursday July 20, 2017. The ...

NeuroMetrix (NURO) Presents At 2017 Marcum Microcap Conference - Slideshow

NeuroMetrix (NURO) Presents At 7th Annual LD Micro Invitational Conference - Slideshow

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

NeuroMetrix, Inc.

NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. To date, our focus has been primarily on the assessment of neuropathies. We a...

NeuroMetrix

NeuroMetrix, Inc. was founded in June 1996 as a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. The Company’s mission is to: Create value for our customers by developi...

More Information about "NeuroMetrix" on BioPortfolio

We have published hundreds of NeuroMetrix news stories on BioPortfolio along with dozens of NeuroMetrix Clinical Trials and PubMed Articles about NeuroMetrix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroMetrix Companies in our database. You can also find out about relevant NeuroMetrix Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record